课题基金 / 基金详情

MODULATION OF THE TUMORIGENICITY OF TRANSFORMED CELLS

MODULATION OF THE TUMORIGENICITY OF TRANSFORMED CELLS
转化细胞致瘤性的调节
批准号:
3166812
负责人:
Mary K. Katherine Howett
金额:
$15.45万
依托单位国家:
美国
项目类别:
财政年份:
1979
资助国家:
美国
项目状态:
已结题
起止时间:
1979-04-01 至 1995-06-30

项目摘要

项目成果

Mary K. Katherine Howett的其他基金

相似基金

相关文献

中文摘要
翻译
实验性人尖锐湿疣可由人乳头瘤病毒引起
英文摘要
Experimental human condylomata can be generated by human papillomavirus type 11 (HPV-11) infection in vitro of human foreskin or human cervix tissue chips and subsequent in vivo transplantation to the renal capsule of athymic mice. Three months after infection, infected xenogafts are classified as mild to moderate dysplasias and resemble, in every measurable way, lesions seen in patients. These experimental condylomata express a full repertoire of HPV-11 genes and make recoverable amounts of infectious HPV-11. Transformed grafts are assumed to have alterations in expression of their cellular transcripts that affect cell phenotype. To date, it has not been possible to productively infect human tissue grafts with HPV-16. HPV-16 DNA, however, can be introduced into human cervix or foreskin keratinocytes, and cells exhibiting extended life span in culture have been derived. Transfection of ras oncogene DNA during or after HPV-16 DNA transfection results in cells that are tumorigenic in nude mice. Transformation of other cell types has also been accomplished. HPV-16 DNA or HPV-16 DNA plus ras DNA transformed cell lines retain copies of the input DNA and mainly express HPV-16 genes. The transformed cells derived in this laboratory and those derived by others are assumed to also have alterations in cellular transcript expressions that affect cell phenotype. Such alterations may differ in whole, or in part, from the ones found in HPV-11 infected cells. The goal of this research program is to identify and characterize the biological significance of such changes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TOPICAL THERAPY FOR HSV-2 INFECTION OF THE GENITAL TRACT
IN VIVO MODELS FOR HUMAN GENITAL TISSUES AND SEXUALLY TRANSMITTED DISEASES
TOPICAL THERAPY FOR HSV-2 INFECTION OF THE GENITAL TRACT
TOPICAL THERAPY FOR HSV-2 INFECTION OF THE FEMALE GENITAL TRACT
海外基金